Cargando…

Immunological Barriers to Stem Cell Therapy in the Central Nervous System

The central nervous system is vulnerable to many neurodegenerative disorders such as Alzheimer's disease that result in the extensive loss of neuronal cells. Stem cells have the ability to differentiate into many types of cells, which make them ideal for treating such disorders. Although stem c...

Descripción completa

Detalles Bibliográficos
Autores principales: Tullis, Gregory E., Spears, Kathleen, Kirk, Mark D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4138731/
https://www.ncbi.nlm.nih.gov/pubmed/25165476
http://dx.doi.org/10.1155/2014/507905
_version_ 1782331274726211584
author Tullis, Gregory E.
Spears, Kathleen
Kirk, Mark D.
author_facet Tullis, Gregory E.
Spears, Kathleen
Kirk, Mark D.
author_sort Tullis, Gregory E.
collection PubMed
description The central nervous system is vulnerable to many neurodegenerative disorders such as Alzheimer's disease that result in the extensive loss of neuronal cells. Stem cells have the ability to differentiate into many types of cells, which make them ideal for treating such disorders. Although stem cell therapy has shown some promising results in animal models for many brain disorders it has yet to translate into the clinic. A major hurdle to the translation of stem cell therapy into the clinic is the immune response faced by stem cell transplants. Here, we focus on immunological and related hurdles to stem cell therapies for central nervous system disorders.
format Online
Article
Text
id pubmed-4138731
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-41387312014-08-27 Immunological Barriers to Stem Cell Therapy in the Central Nervous System Tullis, Gregory E. Spears, Kathleen Kirk, Mark D. Stem Cells Int Review Article The central nervous system is vulnerable to many neurodegenerative disorders such as Alzheimer's disease that result in the extensive loss of neuronal cells. Stem cells have the ability to differentiate into many types of cells, which make them ideal for treating such disorders. Although stem cell therapy has shown some promising results in animal models for many brain disorders it has yet to translate into the clinic. A major hurdle to the translation of stem cell therapy into the clinic is the immune response faced by stem cell transplants. Here, we focus on immunological and related hurdles to stem cell therapies for central nervous system disorders. Hindawi Publishing Corporation 2014 2014-08-05 /pmc/articles/PMC4138731/ /pubmed/25165476 http://dx.doi.org/10.1155/2014/507905 Text en Copyright © 2014 Gregory E. Tullis et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Tullis, Gregory E.
Spears, Kathleen
Kirk, Mark D.
Immunological Barriers to Stem Cell Therapy in the Central Nervous System
title Immunological Barriers to Stem Cell Therapy in the Central Nervous System
title_full Immunological Barriers to Stem Cell Therapy in the Central Nervous System
title_fullStr Immunological Barriers to Stem Cell Therapy in the Central Nervous System
title_full_unstemmed Immunological Barriers to Stem Cell Therapy in the Central Nervous System
title_short Immunological Barriers to Stem Cell Therapy in the Central Nervous System
title_sort immunological barriers to stem cell therapy in the central nervous system
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4138731/
https://www.ncbi.nlm.nih.gov/pubmed/25165476
http://dx.doi.org/10.1155/2014/507905
work_keys_str_mv AT tullisgregorye immunologicalbarrierstostemcelltherapyinthecentralnervoussystem
AT spearskathleen immunologicalbarrierstostemcelltherapyinthecentralnervoussystem
AT kirkmarkd immunologicalbarrierstostemcelltherapyinthecentralnervoussystem